PT - JOURNAL ARTICLE AU - Klaus Pietzner AU - Nina Buttmann-Schweiger AU - Jalid Sehouli AU - Klaus Kraywinkel TI - Incidence Patterns and Survival of Gynecological Sarcoma in Germany: Analysis of Population-Based Cancer Registry Data on 1066 Women AID - 10.1097/IGC.0000000000001128 DP - 2018 Jan 01 TA - International Journal of Gynecologic Cancer PG - 134--138 VI - 28 IP - 1 4099 - http://ijgc.bmj.com/content/28/1/134.short 4100 - http://ijgc.bmj.com/content/28/1/134.full SO - Int J Gynecol Cancer2018 Jan 01; 28 AB - Objective Sarcomas of the female genital tract are rare tumors. They are described to be associated with a poor prognosis when compared with gynecogical carcinoma. The aim of this study was to report incidence patterns and survival rates for gynecological sarcoma (GS) in Germany.Methods/Materials Clinical data and survival rates for patients with GS diagnosed in Germany between 2009 and 2013 were extracted from the German national center for population-based cancer registry data. Incidence patterns and 5-year relative survival rates were calculated.Results A total of 1066 GSs were included in our analysis during a 5-year time span. The uterus was the most common site, with 87.9% of all cases. The annual age-standardized incidence rate (old European standard) was 8.7 per 1 million women for all GSs. The median age at diagnosis was 59 years. The prognosis ranged according to site, stage, and subtype, for example, from a 5-year relative survival of 53.0% (uterine leiomyosarcoma) if confined to the pelvis, to a very good 5-year relative survival of 97.2% (endometrial stromal sarcoma).Conclusions Despite the rareness of GS, the size of the data set allows for a differentiation of subtypes according to morphology and site of origin. Clinically relevant differences in incidence and prognosis between subgroups were observed.